Page 102 - Hang Lung Group 2012 Annual Report

（一）董事局
1. 組成及功能
董事局現有八名成員：
• 三名執行董事，分別為陳啟宗先生、
陳南祿先生及何孝昌先生；
• 一名非執行董事，為陳樂宗先生；及
• 四名獨立非執行董事，分別為殷尚賢
先生、鄭漢鈞博士、陳樂怡女士及葉
錫安先生。彼等均具備適當之學術及
專業資格或相關之財務管理專才，並
以其豐富的商務及財務經驗為董事局
作出貢獻。
高伯遒先生於二零一二年十二月十二日辭
任為本公司執行董事。
本公司及香港交易及結算所有限公司（「香
港交易所」）網頁提供最新的董事名單，列
明其角色和職能，以及註明其是否獨立非
執行董事。董事的履歷詳情於本年報第一
百二十二至第一百二十六頁內披露，並設
存於本公司網頁。
董事局負責（當中包括）：
• 確保領導層之連續性；
• 設定卓越之業務策略；
• 確保資金和管理資源足以應付業務策
略之推行；及
• 確保財務及內部監控制度健全，
業務運作符合適用之法律及規定。
所有董事必須向本公司披露其於公眾公司
或組織擔任的職位及其他重大承擔。
( I ) The Board
1. Composition and Functions
The Board currently comprises eight persons:
• three Executive Directors, namely, Mr Ronnie C. Chan, Mr Philip
N.L. Chen and Mr H.C. Ho;
• one Non-Executive Director, Mr Gerald L. Chan; and
• four Independent Non-Executive Directors, namely, Mr S.S. Yin,
Dr H.K. Cheng, Ms Laura L.Y. Chen and Mr Simon S.O. Ip. They
possess appropriate academic and professional qualifications or
related financial management expertise and have brought a wide
range of business and financial experience to the Board.
Mr William P.Y. Ko resigned as Executive Director of the Company on
December 12, 2012.
An updated list of Board members identifying their roles and functions
and whether they are independent non-executive directors is maintained
on our website and the website of Hong Kong Exchanges and Clearing
Limited (“HKEx”). Their biographical details, disclosed on pages 122 to
126 of this annual report, are also maintained on our website.
The Board is responsible for, among other things:
• ensuring continuity of leadership;
• development of sound business strategies;
• availability of adequate capital and managerial resources to
implement the business strategies adopted; and
• adequacy of systems of financial and internal controls and conduct
of business in conformity with applicable laws and regulations.
All Directors are required to disclose to the Company their offices held in
public companies or organizations and other significant commitments.
102 |